These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 29858579

  • 1. Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer.
    Gupta S, Mani NR, Carvajal-Hausdorf DE, Bossuyt V, Ho K, Weidler J, Wong W, Rhees B, Bates M, Rimm DL.
    Lab Invest; 2018 Aug; 98(8):1076-1083. PubMed ID: 29858579
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Concordance between ER, PR, Ki67, and HER2-low expression in breast cancer by MammaTyper RT-qPCR and immunohistochemistry: implications for the practising pathologist.
    Badr NM, Zaakouk M, Zhang Q, Kearns D, Kong A, Shaaban AM.
    Histopathology; 2024 Sep; 85(3):437-450. PubMed ID: 38651302
    [Abstract] [Full Text] [Related]

  • 4. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
    Laible M, Schlombs K, Kaiser K, Veltrup E, Herlein S, Lakis S, Stöhr R, Eidt S, Hartmann A, Wirtz RM, Sahin U.
    BMC Cancer; 2016 Jul 07; 16():398. PubMed ID: 27389414
    [Abstract] [Full Text] [Related]

  • 5. Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
    Hartmann K, Schlombs K, Laible M, Gürtler C, Schmidt M, Sahin U, Lehr HA.
    Diagn Pathol; 2018 Oct 20; 13(1):83. PubMed ID: 30342538
    [Abstract] [Full Text] [Related]

  • 6. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
    Filipits M, Rudas M, Singer CF, Fitzal F, Bago-Horvath Z, Greil R, Balic M, Lax SF, Halper S, Hulla W, Wu NC, Liu X, Weidler J, Bates M, Hlauschek D, Gnant M, Dubsky P.
    ESMO Open; 2021 Aug 20; 6(4):100228. PubMed ID: 34371382
    [Abstract] [Full Text] [Related]

  • 7. Validation of the Xpert Breast Cancer STRAT 4 Assay on the GeneXpert instrument to Assess Hormone Receptor, Ki67, and HER2 Gene Expression Status in Breast Cancer Tissue Samples.
    Sewanywa L, Hale M, Michelow P, Mayne E, Wiggill T.
    Appl Immunohistochem Mol Morphol; 2023 Oct 01; 31(9):613-620. PubMed ID: 37800656
    [Abstract] [Full Text] [Related]

  • 8. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP, Schneeweiss A, Keller M, Schlombs K, Laible M, Seitz J, Lakis S, Veltrup E, Altevogt P, Eidt S, Wirtz RM, Marmé F.
    BMC Cancer; 2017 Feb 13; 17(1):124. PubMed ID: 28193205
    [Abstract] [Full Text] [Related]

  • 9. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.
    Chen L, Chen Y, Xie Z, Luo J, Wang Y, Zhou J, Huang L, Li H, Wang L, Liu P, Shu M, Zhang W, Ke Z.
    Breast Cancer Res Treat; 2022 Aug 13; 194(3):517-529. PubMed ID: 35789315
    [Abstract] [Full Text] [Related]

  • 10. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
    Janeva S, Parris TZ, Nasic S, De Lara S, Larsson K, Audisio RA, Olofsson Bagge R, Kovács A.
    BMC Cancer; 2021 Apr 21; 21(1):439. PubMed ID: 33879115
    [Abstract] [Full Text] [Related]

  • 11. High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescence.
    Wasserman BE, Carvajal-Hausdorf DE, Ho K, Wong W, Wu N, Chu VC, Lai EW, Weidler JM, Bates M, Neumeister V, Rimm DL.
    Lab Invest; 2017 Dec 21; 97(12):1521-1526. PubMed ID: 28892092
    [Abstract] [Full Text] [Related]

  • 12. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    El Hadi H, Abdellaoui-Maane I, Kottwitz D, El Amrani M, Bouchoutrouch N, Qmichou Z, Karkouri M, ElAttar H, Errihani H, Fernandez PL, Bakri Y, Sefrioui H, Moumen A.
    Gene; 2017 Mar 20; 605():114-122. PubMed ID: 28039034
    [Abstract] [Full Text] [Related]

  • 13. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
    Park S, Wang HY, Kim S, Ahn S, Lee D, Cho Y, Park KH, Jung D, Kim SI, Lee H.
    Int J Clin Exp Pathol; 2014 Mar 20; 7(10):6752-9. PubMed ID: 25400755
    [Abstract] [Full Text] [Related]

  • 14. Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection.
    Tramm T, Hennig G, Kyndi M, Alsner J, Sørensen FB, Myhre S, Sørlie T, Overgaard J.
    Virchows Arch; 2013 Dec 20; 463(6):775-86. PubMed ID: 24100522
    [Abstract] [Full Text] [Related]

  • 15. Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCR.
    Caselli E, Pelliccia C, Teti V, Bellezza G, Mandarano M, Ferri I, Hartmann K, Laible M, Sahin U, Varga Z, Lupi C, Stracci F, Sidoni A.
    PLoS One; 2021 Dec 20; 16(9):e0255580. PubMed ID: 34555047
    [Abstract] [Full Text] [Related]

  • 16. Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.
    Wirtz RM, Sihto H, Isola J, Heikkilä P, Kellokumpu-Lehtinen PL, Auvinen P, Turpeenniemi-Hujanen T, Jyrkkiö S, Lakis S, Schlombs K, Laible M, Weber S, Eidt S, Sahin U, Joensuu H.
    Breast Cancer Res Treat; 2016 Jun 20; 157(3):437-46. PubMed ID: 27220750
    [Abstract] [Full Text] [Related]

  • 17. Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
    Pu T, Guo P, Qiu Y, Chen S, Yang L, Sun L, Ye F, Bu H.
    Int J Clin Exp Pathol; 2015 Jun 20; 8(9):10565-74. PubMed ID: 26617766
    [Abstract] [Full Text] [Related]

  • 18. Breast Cancer Subtype Classification Using 4-Plex Droplet Digital PCR.
    Chen W, Zheng J, Wu C, Liu S, Chen Y, Liu X, Du J, Wang J.
    Clin Chem; 2019 Aug 20; 65(8):1051-1059. PubMed ID: 31010819
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P, Buelow B, Chen YY, Serrano M, Vohra MS, Berry A, Ljung BM.
    Cancer Cytopathol; 2016 Nov 20; 124(11):828-835. PubMed ID: 27315045
    [Abstract] [Full Text] [Related]

  • 20. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR, Rodríguez-Lescure Á, Ebbert MT, Prat A, Munárriz B, Rowe L, Miller P, Ruiz-Borrego M, Anderson D, Lyons B, Álvarez I, Dowell T, Wall D, Seguí MÁ, Barley L, Boucher KM, Alba E, Pappas L, Davis CA, Aranda I, Fauron C, Stijleman IJ, Palacios J, Antón A, Carrasco E, Caballero R, Ellis MJ, Nielsen TO, Perou CM, Astill M, Bernard PS, Martín M.
    BMC Med Genomics; 2012 Oct 04; 5():44. PubMed ID: 23035882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.